Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance signal alteration refers to changes in the intensity or pattern of signals detected by magnetic resonance imaging (MRI) within tissues. These alterations are not a molecule or receptor themselves, but rather represent a radiological phenomenon that reflects underlying tissue characteristics, pathology, or physiological processes. Signal alterations can be intrinsic (due to tissue properties) or extrinsic (due to contrast agents). It's influenced by proton density and relaxation times (T1 and T2). Common patterns include muscle edema, fatty infiltration, and mass lesions. Contrast agents enhance detection sensitivity for certain pathologies. It is crucial for diagnosing a wide range of conditions including traumatic injuries, infections, autoimmune/inflammatory diseases, neoplasms, and neurologic/denervation syndromes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Signal Alteration.